Navigation Links
Nouveau Life Pharmaceuticals (NOUV) to Launch Affiliate Sales Program
Date:6/22/2012

FORT LAUDERDALE, Fla., June 22, 2012 /PRNewswire/ -- Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV), a provider of quality all-natural dietary supplements, announced today that the Company is developing a formal Affiliate Sales Program.

Nouveau Life is currently developing an Affiliate Sales Program as part of its larger strategic marketing plan. The Nouveau Life Affiliate Sales Program will be based on the pay-for-performance model; affiliate partners will be paid a commission on each product sale they generate.  

"An affiliate program is an extremely effective marketing tool to quickly increase brand awareness and product exposure and, in turn, generate more revenue," explained Nouveau Life CEO Melissa Walker. "When implemented properly, an affiliate sales program can grow sales exponentially while requiring little operating capital."

Affiliate partners will be allowed to market and sell all of Nouveau Life's current products, which include Azul: Male Enhancer™, Azul Instant™, New Life Naturals: For Her Senses™, and New Life Naturals: For Your Weight Loss™. As Nouveau Life releases new products to the public, those products will also be added to the Affiliate Sales Program. Affiliate partners will be provided with exclusive sales and marketing tools such as banner ads, coupon codes, promotional email text, and product images.

The Nouveau Life Affiliate Sales Program is slated to be launched within the next two weeks. Watch for additional information on the Nouveau Life website at www.nlpnaturals.com.

About Nouveau Life Pharmaceuticals

The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements - This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

CONTACT:

Nouveau Life Pharmaceuticals, Inc. - 954-903-2993


'/>"/>
SOURCE Nouveau Life Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
2. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. Trading Of Onyx Pharmaceuticals Common Stock Halted
5. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
6. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
7. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
8. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
9. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
10. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
11. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ... honored with a 2016 When Work Works Award for its use of effective workplace ... national When Work Works project administered by the Families and Work Institute (FWI) and ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, ... who lost their lives in military battle for the country. The nonprofit Hope ... to provide more programs that empower independence for disabled military veterans, as well as ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership ... solutions, today announced the organization has earned its ISO 13485 certification, indicating the ... compliant with all rules and policies associated with ISO quality standard 13485. ...
(Date:5/26/2016)... New York, NY (PRWEB) , ... May 26, ... ... cell researcher, founder of Mehling Orthopedics and chief medical officer of Blue Horizon ... Musculoskeletal Disease and Regeneration. The conference was held during May 5-6, 2016 in ...
Breaking Medicine News(10 mins):